Staged Gamma Knife with bevacizumab is associated with earlier vestibular schwannoma regression
Early tumor enlargement occurred in 14.3% with staged Gamma Knife plus bevacizumab versus 60.9% with single-session radiosurgery alone.
Early tumor enlargement occurred in 14.3% with staged Gamma Knife plus bevacizumab versus 60.9% with single-session radiosurgery alone.
Gamma Knife and LINAC radiosurgery produced similarly high control and low new neurologic symptoms in 85 vestibular schwannoma patients.
Gamma Knife radiosurgery achieved 73.53% 5-year progression-free survival in a small postoperative papillary craniopharyngioma cohort.
A multimodal imaging, radiomics, and clinical deep learning model showed moderate external validation for survival risk after Gamma Knife radiosurgery.